$609Million | No. of Holdings #46
Prosight Management, LP Performance
| Ticker | $ Bought |
|---|---|
| alkermes plc | 18,162,000 |
| schrodinger inc | 5,800,170 |
| emergent biosolutions inc | 5,304,680 |
| icu med inc | 3,545,170 |
| upstream bio inc | 2,170,110 |
| omeros corp | 1,845,890 |
| intuitive surgical inc | 1,843,960 |
| an2 therapeutics inc | 1,763,880 |
| Ticker | % Inc. |
|---|---|
| genedx holdings corp | 851 |
| abivax sa | 517 |
| alnylam pharmaceuticals inc | 344 |
| boston scientific corp | 278 |
| onkure therapeutics inc | 163 |
| orthopediatrics corp | 121 |
| terns pharmaceuticals inc | 112 |
| shattuck labs inc | 110 |
| Ticker | % Reduced |
|---|---|
| roivant sciences ltd | -71.3 |
| tectonic therapeutic inc | -66.01 |
| trueblue inc | -43.71 |
| concentra group holdings par | -43.23 |
| immunovant inc | -27.76 |
| meiragtx hldgs plc | -18.06 |
| rocket pharmaceuticals inc | -8.08 |
| rein therapeutics inc | -7.00 |
| Ticker | $ Sold |
|---|---|
| amicus therapeutics inc | -16,376,000 |
| select med hldgs corp | -15,371,000 |
| avantor inc | -10,296,800 |
| caredx inc | -4,710,000 |
| icon plc | -20,044,200 |
| tempus ai inc | -2,066,750 |
| labcorp holdings inc | -8,663,390 |
| bridgebio pharma inc | -2,294,700 |
Prosight Management, LP has about 73.1% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 73.1 |
| Others | 21.2 |
| 5.5 |
Prosight Management, LP has about 15.9% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| SMALL-CAP | 41.1 |
| UNALLOCATED | 21.2 |
| LARGE-CAP | 15.9 |
| MID-CAP | 14.1 |
| MICRO-CAP | 7.3 |
About 52% of the stocks held by Prosight Management, LP either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| Others | 48 |
| RUSSELL 2000 | 43.5 |
| S&P 500 | 8.5 |
This heatmap illustrates the top 50 positions within the fund's portfolio.
Prosight Management, LP has 46 stocks in it's portfolio. About 65% of the portfolio is in top 10 stocks. SMFR proved to be the most loss making stock for the portfolio. NKTR was the most profitable stock for Prosight Management, LP last quarter.
| Expand | Holdingsorted ascending | % Portfolio | Shares Held | $ Value | % Change |
|---|---|---|---|---|---|
Adicet Bio Inc Adicet Bio IncACET Prosight Management, LP's holding in Adicet Bio Inc over time | 0.28% | 250,244 | $1.70M 0.28% | 0%unchanged 0 percentunchanged | |
ADCT Adc Therapeutics SaAdc Therapeutics SaADCT | 5.1% | 8,300,000 | $31.13M 5.1% | 2.09%decreased 2.09 percentreduced | |
Alkermes Plc Alkermes PlcALKS Prosight Management, LP's holding in Alkermes Plc over time | 2.98% | 513,632 | $18.16M 2.98% | Newnew position | |
Alnylam Pharmaceuticals Inc Prosight Management, LP's holding in Alnylam Pharmaceuticals Inc over time | 4.12% | 76,000 | $25.15M 4.12% | 344.21%increased 344.21 percentadded | |
Rein Therapeutics Inc Prosight Management, LP's holding in Rein Therapeutics Inc over time | 0.09% | 411,600 | $535.1K 0.09% | 7%decreased 7 percentreduced | |
An2 Therapeutics Inc Prosight Management, LP's holding in An2 Therapeutics Inc over time | 0.29% | 515,754 | $1.76M 0.29% | Newnew position | |
Avantor Inc Avantor IncAVTR Prosight Management, LP's holding in Avantor Inc over time | 0% | 0.00 | $0.00 0% | 100%decreased 100 percentsold off | |
Bridgebio Pharma Inc Prosight Management, LP's holding in Bridgebio Pharma Inc over time | 0% | 0.00 | $0.00 0% | 100%decreased 100 percentsold off | |
Boston Scientific Corp Prosight Management, LP's holding in Boston Scientific Corp over time | 8.19% | 795,547 | $49.92M 8.19% | 278.83%increased 278.83 percentadded | |
Caredx Inc Caredx IncCDNA Prosight Management, LP's holding in Caredx Inc over time | 0% | 0.00 | $0.00 0% | 100%decreased 100 percentsold off | |
Corbus Pharmaceuticals Hldgs Prosight Management, LP's holding in Corbus Pharmaceuticals Hldgs over time | 1.07% | 697,108 | $6.55M 1.07% | 1.94%increased 1.94 percentadded | |
Crinetics Pharmaceuticals In Prosight Management, LP's holding in Crinetics Pharmaceuticals In over time | 2.08% | 350,000 | $12.71M 2.08% | 33.13%increased 33.13 percentadded | |
Emergent Biosolutions Inc Prosight Management, LP's holding in Emergent Biosolutions Inc over time | 0.87% | 639,118 | $5.30M 0.87% | Newnew position | |
Amicus Therapeutics Inc Prosight Management, LP's holding in Amicus Therapeutics Inc over time | 0% | 0.00 | $0.00 0% | 100%decreased 100 percentsold off | |
GLPG Galapagos NvGalapagos NvGLPG | 7.62% | 1,550,000 | $46.50M 7.62% | 44.31%increased 44.31 percentadded | |
ICLR Icon PlcIcon PlcICLR | 0% | 0.00 | $0.00 0% | 100%decreased 100 percentsold off | |
Icu Med Inc Icu Med IncICUI Prosight Management, LP's holding in Icu Med Inc over time | 0.58% | 27,450 | $3.55M 0.58% | Newnew position | |
Immuneering Corp Immuneering CorpIMRX Prosight Management, LP's holding in Immuneering Corp over time | 0.11% | 123,409 | $650.4K 0.11% | Newnew position | |
Immunovant Inc Immunovant IncIMVT Prosight Management, LP's holding in Immunovant Inc over time | 0.72% | 175,825 | $4.37M 0.72% | 27.76%decreased 27.76 percentreduced | |
Irhythm Holdings Inc Prosight Management, LP's holding in Irhythm Holdings Inc over time | 0.19% | 10,000 | $1.18M 0.19% | Newnew position | |